The Most Complete and Accurate Human Growth Hormone Guide in the World
HGH » HGH Articles » HGH For Adults
HGH For Adults
Read the Following article on "HGH For Adults".
What Influence Does the Human Growth Hormone have on Adults?
Growth hormone deficiency (GHD) is observed in adults in two forms. One is childhood onset GHD and the other is adult onset GHD.
Important causes of GHD include: tumors of the pituitary, irradiation to the skull and trauma or injury to the brain. This deficiency leads to several changes in the body’s constitution, fat metabolism, cardiovascular condition, bone mineral density and so on. The use of recombinant growth hormone therapy has been a breakthrough for adults suffering from the condition.
Recombinant growth hormone therapy brings a lot of positive changes in the body constitution of the adults. In a clinical trial, the hormone was given in low doses of 0.003 mg/kg to 24 adults with GH deficiency, for six months. Results demonstrated: increase in lean muscle mass, reduction in the fat deposits, augmented muscle protein synthesis, boosted energy levels, strengthened immunity and general well being. It was also found in one study that, there occurred a significant reduction in LDL or low density lipoprotein and enhancement in HDL or high density lipoprotein after administering the recombinant hormone.
In another study conducted, five adults who were under hemodialysis, were given growth hormone therapy. The hormone was administered subcutaneously, 5 mg or 10 mg after every dialysis session for 2 weeks. Consequently, there was a reduction in the urea release and catabolism of proteins during the treatment period. This study revealed that this hormone treatment in adults reduced the break down of dietary proteins taken in by the hemodialysis patients.
Another major study was conducted by Andrea F Attanasio, published in the Journal of Clinical Endocrinology and Metabolism in 2002. In this study, 1123 adult onset GHD patients and 362 childhood onset GHD adults were studied. The growth hormone replacement therapy was given to them at a dosage of 0.04 to 0.08 mg/kg/week.
Results seen were: enhancement in the lean muscle mass, decrease in the fat content of the body, elevated energy levels, reduction in the signs of aging, mental stability and overall well being. The harmless body mass, height and BMI were considerably lesser in the childhood onset group than the other group. After treatment for three years, the lean mass of the body was enhanced in males and females of adult onset group and only in males of childhood onset group. The fat content was conspicuously decreased in adult onset males only. HDL cholesterol was increased in females and males. The lean mass of the body was increased in adult onset group below the age of 40, than in the aged people of that group.
Growth hormone deficiency (GHD) is observed in adults in two forms. One is childhood onset GHD and the other is adult onset GHD.
Important causes of GHD include: tumors of the pituitary, irradiation to the skull and trauma or injury to the brain. This deficiency leads to several changes in the body’s constitution, fat metabolism, cardiovascular condition, bone mineral density and so on. The use of recombinant growth hormone therapy has been a breakthrough for adults suffering from the condition.
Recombinant growth hormone therapy brings a lot of positive changes in the body constitution of the adults. In a clinical trial, the hormone was given in low doses of 0.003 mg/kg to 24 adults with GH deficiency, for six months. Results demonstrated: increase in lean muscle mass, reduction in the fat deposits, augmented muscle protein synthesis, boosted energy levels, strengthened immunity and general well being. It was also found in one study that, there occurred a significant reduction in LDL or low density lipoprotein and enhancement in HDL or high density lipoprotein after administering the recombinant hormone.
In another study conducted, five adults who were under hemodialysis, were given growth hormone therapy. The hormone was administered subcutaneously, 5 mg or 10 mg after every dialysis session for 2 weeks. Consequently, there was a reduction in the urea release and catabolism of proteins during the treatment period. This study revealed that this hormone treatment in adults reduced the break down of dietary proteins taken in by the hemodialysis patients.
Another major study was conducted by Andrea F Attanasio, published in the Journal of Clinical Endocrinology and Metabolism in 2002. In this study, 1123 adult onset GHD patients and 362 childhood onset GHD adults were studied. The growth hormone replacement therapy was given to them at a dosage of 0.04 to 0.08 mg/kg/week.
Results seen were: enhancement in the lean muscle mass, decrease in the fat content of the body, elevated energy levels, reduction in the signs of aging, mental stability and overall well being. The harmless body mass, height and BMI were considerably lesser in the childhood onset group than the other group. After treatment for three years, the lean mass of the body was enhanced in males and females of adult onset group and only in males of childhood onset group. The fat content was conspicuously decreased in adult onset males only. HDL cholesterol was increased in females and males. The lean mass of the body was increased in adult onset group below the age of 40, than in the aged people of that group.